Location: Home
  • search
  • go
  • Relate News
  • 7/19/2022WuXi STA Opens a New Large Scale Continuous Manufacturing Plant
  • 7/19/2022WuXi AppTec Plans to Build a New Site in Singapore with Planned S$2B I...
  • 7/14/2022CStone Considers Sale Amid Mounting Challenges: Bloomberg
  • 7/7/2022Pharmaron Acquires Commercial API Manufacturing Facility in the U.S.
  • 7/1/2022Eurofins DiscoverX Establishes A New China Biotechnology Office
  • 6/29/2022WuXi STA Opens Another High-Potency API Plant In Changzhou
  • 6/23/2022GlobalData: Borrena (lorlatinib) Approval Further Strengthens Pfizer P...
  • 6/7/2022CanSino and Pfizer Terminate vaccine deal
  • 6/6/2022WuXi Biologics Launches First Commercial Drug Product Facility for Pre...
  • 6/3/2022NeoGenomics's Suzhou Pharma Services Lab Gets CAP Certification
  • 5/24/2022Vir and WuXi Bio Terminate COVID Antibody Agreement
  • 5/23/2022Fujifilm Completes Construction of Bioprocessing Innovation & Collabor...
  • 5/23/2022Biopharma in China: The Emerging Global Force of Domestic Suppliers
  • 5/2/2022Pfizer Wins Chinese Approval of lorlatinib for ALK-positive Advanced N...
  • 4/28/2022Stevanato Group Acquires Manufacturing Facility in Zhejiang to Suppor...
  • 4/18/2022VectorBuilder to Build $500M Gene Therapy Manufacturing Facility in Ch...
  • 4/12/2022Pfizer Wins Chinese Approval of JAK1 Inhibitor Abrocitinib for moderat...
  • 4/11/2022Decentralized CRO Science 37 Expands in the Asia-Pacific including Chi...
  • 4/7/2022The Chinese Pharma CMO Market to Reach $13B in 2030, Predicts Roots An...
  • 4/7/2022CDMO Asymchem Completes Expansion of  Chinese Manufactuing Facilitie...
  • 3/24/2022Fosun Reports Over CNY 1B of BioNTech mRNA Vaccine Sales in 2021 Despi...
  • 3/17/2022Five Chinese Firms Agree to Make Generic Version of Pfizer's Oral COVI...
  • 3/16/2022Pfizer COVID-19 Pill Added to Pandemic Treatment Guidelines in China ...
  • 3/11/2022Pharma CMO Stevanato Group Expands Capacity in China with New Facility
  • 3/9/2022Lonza Expands API Development and Manufacturing Laboratories in Nansha
  • 3/9/2022China Meheco Inks Deal to Market Pfizer's Covid Pill Paxlovid in China
  • 3/3/2022WuXi STA Passes the First EMA Drug Product Pre-Approval Inspection at ...
  • 2/14/2022Chinese CDMO Asymchem to Expand in the U.S. thru Acquisition of Snapdr...
  • 2/14/2022Bloomberg: China's Approval of Pfizer Pill Opens Door to Ending Its 'C...
  • 2/13/2022China Approves Pfizer's Covid Drug Paxlovid Conditionally
  • Page:4/25 Total number of articles:744: [First][<<] [2] [3] [4] [5] [6] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group